Prostanoid therapy for pulmonary arterial hypertension
- 1 June 2004
- journal article
- review article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 43 (12) , S56-S61
- https://doi.org/10.1016/j.jacc.2004.02.036
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Survival in Primary Pulmonary HypertensionCirculation, 2002
- Inhaled Iloprost for Severe Pulmonary HypertensionNew England Journal of Medicine, 2002
- Ultrasonicversusjet nebulization of iloprost in severe pulmonary hypertensionEuropean Respiratory Journal, 2001
- Long-Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin AnalogueNew England Journal of Medicine, 2000
- Reduction in Pulmonary Vascular Resistance with Long-Term Epoprostenol (Prostacyclin) Therapy in Primary Pulmonary HypertensionNew England Journal of Medicine, 1998
- Short-term hemodynamic effect of a new oral PGI2 analogue, Beraprost, in primary and secondary pulmonary hypertensionThe American Journal of Cardiology, 1996
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Positive inotropic and chronotropic effects of beraprost sodium, a stable analogue of prostacyclin, in isolated guinea pig myocardiumGeneral Pharmacology: The Vascular System, 1996
- Protective Effect of Beraprost Sodium, a Stable Prostacyclin Analogue, in Development of Monocrotaline-Induced Pulmonary HypertensionJournal of Cardiovascular Pharmacology, 1996
- Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertensionThe Lancet, 1991